<DOC>
	<DOCNO>NCT01001520</DOCNO>
	<brief_summary>This study test hypothesis medication call tolcapone ( Brand Name : Tasmar ) help reduce cognitive problem smoker experience quit . This study also determine whether benefit medication differ depend smoker ' genetic background .</brief_summary>
	<brief_title>Neural Substrates Nicotine Withdrawal</brief_title>
	<detailed_description>Tolcapone , FDA-approved treatment Parkinson 's disease , improve cognitive performance healthy control COMT val/val genotype , putatively increase prefrontal dopamine level . We propose within-subject double-blind cross-over neuroimaging study short-term ( 11 day ) treatment tolcapone ( vs. placebo ) . Thirty chronic smoker ( 15 val/val genotype 15 val/met met/met genotype ) undergo blood oxygenation level dependent ( BOLD ) fMRI two medication period : 1. 24 hour monitor abstinence tolcapone , 2. 24 hour monitor abstinence placebo ( medication order counterbalance least 10-day washout ) . The BOLD fMRI data acquire subject perform work memory task ( Fractal N-back ) , sustain attention task ( Continuous Performance Task ; CPT ) , response inhibition task ( Go/No-Go ) . The primary outcome medication effect ( within subject ) task-related BOLD activation 24 hour abstinence . Changes behavioral performance subjective symptom examine relation brain activity change . The propose study provide critical mechanistic understanding role COMT abstinence-induced cognitive symptom promote smoke relapse . Information obtain study may establish cognitive performance measure endophenotypes nicotine dependence .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Tolcapone</mesh_term>
	<criteria>Smokers 18 65 year age selfreport smoke least 10 cigarette ( menthol nonmenthol ) per day least last 6 month . Healthy determine Study Physician , base medical evaluation include medical history physical examination , psychiatric evaluation , liver function test ( LFTs GGT enzyme level ) . Capable give write informed consent , include compliance requirement restriction list combined consent HIPAA form . Women childbearing potential must consent use medically accept method birth control participate study ( e.g. , condoms spermicide , oral contraceptive , Depoprovera injection , contraceptive patch , tubal ligation ) 3 month regular menstrual cycle . Capable provide Carbon Monoxide ( CO ) breath test reading great 10 part per million ( ppm ) medical screen visit . Smoking behavior Current enrollment plan enroll another research smoke cessation program next 3 month . Provide CO read less equal 10ppm medical screen visit . Plans use nicotine substitute ( gum , patch , lozenge , ecigarette ) enrol study . Alcohol/Drug Exclusion : History ( past 2 year ) current diagnosis substance abuse and/or currently receive treatment substance abuse ( alcohol , THC , cocaine , PCP , amphetamine , methamphetamine , MDMA/ecstasy , opiates , methadone , benzodiazepine , tricyclic antidepressant , barbiturate ) . Current alcohol consumption exceed 21 standard drinks/week last 6 month . Positive urine drug screen ( substance list previously ) medical screen visit either test day . Breath Alcohol Concentration ( BrAC ) assessment great equal 0.01 medical screen visit either test day . Medication Current use recent discontinuation ( within last 28 day ) medication include follow : Any form psychotropic medication include : Antipsychotics ; Moodstabilizers ( e.g. , lithium , valproic acid , carbamazepine/tegretol ) ; Antidepressants ( tricyclic , SSRI 's , MAOI 's , nonselective MAOIs , Wellbutrin , St. John 's Wort ) ; Antianxiety/Antipanic agent ; Antiobsessive agent ; Prescription stimulant ( e.g. , Provigil , Ritalin ) ; Diet Pills/Anorectics ; Systemic Steroids ; Daily medication chronic pain ( e.g. , opiates ) muscle spasm ; Daily use counter stimulant pill form ( e.g. , ephedrine ) Anticoagulants ( e.g. , Warfarin ) Any heart medication ( e.g. , dobutamine , isoproterenol ) Daily medication asthma Parkinson 's disease medication ( e.g. , levodopa , methyldopa , apomorphine ) Sympathomimetic ( e.g. , albuterol , pseudoephedrine ) Other smoke cessation medication ( Wellbutrin/Zyban , Chantix/varenicline ) Medical Women pregnant , plan pregnancy within next 3 month , lactate . History current diagnosis Axis 1 disorder identify MINI ( Mini International Neuropsychiatric Interview ) selfreport . For major depression , current diagnosis exclusionary . History current diagnosis AttentionDeficit Hyperactivity Disorder ( ADHD ) . Serious unstable disease ( e.g. , cancer within past 6 month [ except squamous cell carcinoma ] , HIV , Parkinson 's disease ) . History epilepsy seizure disorder . History current diagnosis ( last 6months ) abnormal rhythm and/or tachycardia ( &gt; 100 beats/minute ) ; history current diagnosis COPD , cardiovascular disease ( stroke , angina , coronary heart disease ) ; heart attack last 6 month ; uncontrolled hypertension ( SBP &gt; 150 DBP &gt; 90 ) . History current kidney and/or liver failure ( include transplant ) , disease , impairment ( e.g. , cirrhosis ) ; history current diagnosis hepatitis ( exclude hepatitis A ) ; liver function test 20 % outside normal range ; Gammaglutamyl Transpepsidase ( GGT ) value great 20 % outside normal range . Allergy study medication , tolcapone ( Tasmar ) . History severe , uncontrolled muscle movement ( e.g. , uncontrolled jerking , twitch ) certain severe muscle problem ( rhabdomyolysis ) . Low borderline intellectual functioning determine receive score less 90 Shipley Institute Living Scale ( SILS ) correlate Wechsler Adult Intelligence ScaleRevised ( WAISR ) Estimated IQ Test ( administer medical screen visit ) . Experience dizziness lightheadedness upon stand daily basis . Lifetime history stroke . fMRI Selfreported history claustrophobia . Lefthandedness . Color blindness . Any impairment preventing subject use response pad necessary cognitive testing . Circumstances condition may interfere magnetic resonance imaging ( MRI ) . Having cochlear implant wear bilateral hearing aid . Selfreported history head trauma ( include knock unconscious 3 minute great diagnosis concussion ) CNS tumor . Selfreported use pacemaker , certain metallic implant , presence metal eye contraindicate MRI . History gunshot wound . Weight great 300lbs . medical screen either test day . Completion cognitive test study # 810493 # 811325 within last 6 month . Genetic Profile In order balance distribution male female , participant meet genotype eligibility criterion may enrol study . General Any medical condition concomitant medication could compromise subject safety treatment , determine Principal Investigator and/or Study Physician . Inability provide inform consent complete study task determine Principal Investigator and/or Study Physician .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Genetics</keyword>
	<keyword>Nicotine</keyword>
	<keyword>Cognition</keyword>
	<keyword>fMRI</keyword>
</DOC>